CNTB Financial Statements

Balance sheet, income statement, cash flow, and dividends for Connect Biopharma Holdings Ltd (CNTB).


$76.10M Market Cap.

As of 03/31/2025 5:00 PM ET (MRY) • Disclaimer

CNTB Market Cap. (MRY)


CNTB Shares Outstanding (MRY)


CNTB Assets (MRY)


Total Assets

$101.28M

Total Liabilities

$9.12M

Total Investments

$15.48M

CNTB Income (MRY)


Revenue

$26.03M

Net Income

-$15.63M

Operating Expense

$48.48M

CNTB Cash Flow (MRY)


CF Operations

-$23.61M

CF Investing

-$3.45M

CF Financing

$227.00K

CNTB Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

-

-

0%

-

CNTB Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$101,284,000 (-19.55%)

$125,892,000 (-89.61%)

$1,211,930,000 (-34.69%)

$1,855,659,000 (71.05%)

Assets Current

$96,961,000 (-19.85%)

$120,971,000 (-88.85%)

$1,084,937,000 (-38.15%)

$1,754,135,000 (65.99%)

Assets Non-Current

$4,323,000 (-12.15%)

$4,921,000 (-96.12%)

$126,993,000 (25.09%)

$101,524,000 (261.68%)

Goodwill & Intangible Assets

$53,000 (-14.52%)

$62,000 (-87.58%)

$499,000 (-10.89%)

$560,000 (63.74%)

Shareholders Equity

$92,166,000 (-8.79%)

$101,043,000 (-90.79%)

$1,096,870,000 (-36.81%)

$1,735,831,000 (269.36%)

Property Plant & Equipment Net

$4,237,000 (-10.37%)

$4,727,000 (-91.99%)

$58,996,000 (-28.19%)

$82,158,000 (944.20%)

Cash & Equivalents

$78,232,000 (-26.20%)

$106,007,000 (-80.74%)

$550,274,000 (-67.76%)

$1,706,880,000 (68.99%)

Accumulated Other Comprehensive Income

-$1,666,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$164,000 (-98.81%)

$13,725,000 (202.38%)

$4,539,000 (-9.22%)

$5,000,000 (0%)

Total Investments

$15,476,000 (22.38%)

$12,646,000 (-97.81%)

$576,994,000 (0%)

$0 (0%)

Investments Current

$15,476,000 (22.38%)

$12,646,000 (-97.53%)

$511,250,000 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$65,744,000 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$789,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$342,000 (-96.79%)

$10,659,000 (-90.09%)

$107,523,000 (-5.71%)

$114,035,000 (204.96%)

Accumulated Retained Earnings (Deficit)

-$345,355,000 (35.97%)

-$539,347,000 (83.01%)

-$3,175,220,000 (-33.52%)

-$2,378,165,000 (-121.98%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$178,000 (-61.72%)

$465,000 (-84.49%)

$2,998,000 (278.06%)

$793,000 (-13.14%)

Debt Current

$154,000 (-45.96%)

$285,000 (-77.98%)

$1,294,000 (105.40%)

$630,000 (4.30%)

Debt Non-Current

$24,000 (-86.67%)

$180,000 (-89.44%)

$1,704,000 (945.40%)

$163,000 (-47.25%)

Total Liabilities

$9,118,000 (-63.31%)

$24,849,000 (-78.40%)

$115,060,000 (-3.98%)

$119,828,000 (-94.32%)

Liabilities Current

$8,462,000 (-65.13%)

$24,264,000 (-77.70%)

$108,817,000 (-5.10%)

$114,665,000 (201.77%)

Liabilities Non-Current

$656,000 (12.14%)

$585,000 (-90.63%)

$6,243,000 (20.92%)

$5,163,000 (-99.75%)

CNTB Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$26,033,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$19,229,000 (32.48%)

$14,515,000 (-89.59%)

$139,444,000 (13.88%)

$122,445,000 (156.59%)

Research & Development Expense

$29,256,000 (-43.64%)

$51,913,000 (-92.04%)

$652,211,000 (25.90%)

$518,021,000 (243.21%)

Operating Expenses

$48,485,000 (-21.89%)

$62,074,000 (-92.29%)

$805,589,000 (27.58%)

$631,436,000 (219.29%)

Interest Expense

$0 (0%)

$23,000 (-84.03%)

$144,000 (227.27%)

$44,000 (-98.48%)

Income Tax Expense

$223,000 (85.83%)

$120,000 (-94.11%)

$2,037,000 (20.04%)

$1,697,000 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$15,628,000 (73.74%)

-$59,503,000 (92.53%)

-$797,055,000 (39.01%)

-$1,306,824,000 (-67.71%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$15,628,000 (73.74%)

-$59,503,000 (92.53%)

-$797,055,000 (39.01%)

-$1,306,824,000 (-67.71%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$15,628,000 (73.74%)

-$59,503,000 (92.53%)

-$797,055,000 (39.01%)

-$1,306,824,000 (-67.71%)

Weighted Average Shares

$55,213,000 (0.31%)

$55,041,247 (-4.15%)

$57,422,870 (-0.11%)

$57,483,410 (6.57%)

Weighted Average Shares Diluted

$55,213,000

-

-

-

Earning Before Interest & Taxes (EBIT)

-$15,405,000 (74.05%)

-$59,360,000 (92.53%)

-$794,874,000 (39.09%)

-$1,305,083,000 (-68.11%)

Gross Profit

$26,033,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$22,452,000 (63.83%)

-$62,074,000 (92.29%)

-$805,589,000 (-27.58%)

-$631,436,000 (-219.29%)

CNTB Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$3,451,000 (-104.59%)

$75,155,000 (113.15%)

-$571,310,000 (-1579.09%)

-$34,025,000 (-1260.47%)

Net Cash Flow from Financing

$227,000 (192.28%)

-$246,000 (60.64%)

-$625,000 (-100.05%)

$1,316,099,000 (43.25%)

Net Cash Flow from Operations

-$23,612,000 (50.74%)

-$47,930,000 (92.95%)

-$679,665,000 (-24.73%)

-$544,926,000 (-225.99%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$27,431,000 (-201.68%)

$26,979,000 (102.16%)

-$1,251,600,000 (-269.79%)

$737,148,000 (-2.30%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

-$2,701,000 (-103.72%)

$72,590,000 (113.39%)

-$541,990,000 (-4113.55%)

$13,504,000 (-25.95%)

Capital Expenditure

-$750,000 (-128.31%)

$2,649,000 (109.03%)

-$29,320,000 (37.91%)

-$47,225,000 (-215.78%)

Issuance (Repayment) of Debt Securities

$0 (0%)

-$290,000 (80.86%)

-$1,515,000 (-88.20%)

-$805,000 (-49.63%)

Issuance (Purchase) of Equity Shares

$227,000 (415.91%)

$44,000 (-95.06%)

$890,000 (-99.94%)

$1,428,344,000 (0%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

-$595,000 (-3405.56%)

$18,000 (-99.98%)

$94,994,000 (335.46%)

-$40,344,000 (24.49%)

Share Based Compensation

$6,728,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Depreciation Amortization & Accretion

$660,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

CNTB Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00%

-

-

-

Profit Margin

-60.00%

-

-

-

EBITDA Margin

-56.60%

-

-

-

Return on Average Equity (ROAE)

-16.10% (65.00%)

-46.00% (18.29%)

-56.30% (84.69%)

-367.70% (-412.14%)

Return on Average Assets (ROAA)

-13.70% (65.49%)

-39.70% (23.65%)

-52.00% (41.51%)

-88.90% (16.84%)

Return on Sales (ROS)

-59.20%

-

-

-

Return on Invested Capital (ROIC)

-267.10% (-70.45%)

-156.70% (41.88%)

-269.60% (92.59%)

-3639.70% (-74.57%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0%

Price to Earnings Ratio (P/E)

-4.93 (-350.96%)

-1.09 (-162.11%)

-0.42 (68.36%)

-1.32

Price to Sales Ratio (P/S)

2.93

-

-

-

Price to Book Ratio (P/B)

0.83 (28.46%)

0.64 (102.84%)

0.32 (-70.94%)

1.09

Debt to Equity Ratio (D/E)

0.1 (-59.76%)

0.25 (134.29%)

0.1 (52.17%)

0.07 (103.35%)

Earnings Per Share (EPS)

-0.28 (74.07%)

-1.08 (92.55%)

-14.5 (42.00%)

-25 (45.18%)

Sales Per Share (SPS)

0.47 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-0.44 (46.42%)

-0.82 (93.33%)

-12.35 (-19.86%)

-10.3 (-205.12%)

Book Value Per Share (BVPS)

1.67 (-9.10%)

1.84 (-90.39%)

19.1 (-36.74%)

30.2 (258.92%)

Tangible Assets Book Value Per Share (TABVPS)

1.83 (-19.82%)

2.29 (-89.16%)

21.1 (-34.63%)

32.27 (60.51%)

Enterprise Value Over EBIT (EV/EBIT)

2 (0%)

0 (0%)

1 (0%)

0

Enterprise Value Over EBITDA (EV/EBITDA)

2.29 (790.66%)

0.26 (-65.96%)

0.76 (788.24%)

0.09

Asset Turnover

0.23 (0%)

0 (0%)

0 (0%)

0 (0%)

Current Ratio

11.46 (129.80%)

4.99 (-49.99%)

9.97 (-34.83%)

15.3 (-45.00%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$24,362,000 (46.20%)

-$45,281,000 (93.61%)

-$708,985,000 (-19.73%)

-$592,151,000 (-225.15%)

Enterprise Value (EV)

-$33,750,846 (-121.31%)

-$15,250,444 (82.30%)

-$86,139,513 (-398.92%)

-$17,265,237

Earnings Before Tax (EBT)

-$15,405,000 (74.06%)

-$59,383,000 (92.53%)

-$795,018,000 (39.09%)

-$1,305,127,000 (-67.49%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$14,745,000 (75.16%)

-$59,360,000 (92.53%)

-$794,874,000 (39.09%)

-$1,305,083,000 (-68.11%)

Invested Capital

$14,715,000 (470.10%)

-$3,976,000 (-100.72%)

$555,338,000 (1516.85%)

$34,347,000 (-8.08%)

Working Capital

$88,499,000 (-8.49%)

$96,707,000 (-90.09%)

$976,120,000 (-40.46%)

$1,639,470,000 (60.92%)

Tangible Asset Value

$101,231,000 (-19.55%)

$125,830,000 (-89.61%)

$1,211,431,000 (-34.70%)

$1,855,099,000 (71.05%)

Market Capitalization

$76,098,154 (17.17%)

$64,948,671 (30.34%)

$49,831,567 (-83.17%)

$296,039,562

Average Equity

$96,831,500 (-25.09%)

$129,267,500 (-90.87%)

$1,416,350,500 (298.47%)

$355,443,000 (153.72%)

Average Assets

$114,329,500 (-23.76%)

$149,952,500 (-90.22%)

$1,533,794,500 (4.32%)

$1,470,264,000 (101.76%)

Invested Capital Average

$5,768,500 (-84.77%)

$37,881,000 (-87.15%)

$294,842,500 (722.27%)

$35,857,000 (-3.70%)

Shares

55,143,590 (0.19%)

55,041,247 (-4.15%)

57,422,870 (-0.11%)

57,483,410 (6.57%)